128 related articles for article (PubMed ID: 33215431)
1. LncRNA ZFPM2-AS1 aggravates the malignant development of breast cancer via upregulating JMJD6.
Zhao YF; Li L; Li HJ; Yang FR; Liu ZK; Hu XW; Wang Q
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11139-11147. PubMed ID: 33215431
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA ZFPM2-AS1 promotes the tumorigenesis of renal cell cancer via targeting miR-137.
Liu JG; Wang HB; Wan G; Yang MZ; Jiang XJ; Yang JY
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5675-5681. PubMed ID: 31298319
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma.
Liu W; Zhang GQ; Zhu DY; Wang LJ; Li GT; Xu JG; Jin XL; Zhu YM; Yang XY
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7612-7620. PubMed ID: 32744687
[TBL] [Abstract][Full Text] [Related]
5. ZFPM2-AS1, a novel lncRNA, attenuates the p53 pathway and promotes gastric carcinogenesis by stabilizing MIF.
Kong F; Deng X; Kong X; Du Y; Li L; Zhu H; Wang Y; Xie D; Guha S; Li Z; Guan M; Xie K
Oncogene; 2018 Nov; 37(45):5982-5996. PubMed ID: 29985481
[TBL] [Abstract][Full Text] [Related]
6. Long Noncoding RNA ZFPM2-AS1 Knockdown Restrains the Development of Retinoblastoma by Modulating the MicroRNA-515/HOXA1/Wnt/β-Catenin Axis.
Lyv X; Wu F; Zhang H; Lu J; Wang L; Ma Y
Invest Ophthalmol Vis Sci; 2020 Jun; 61(6):41. PubMed ID: 32561925
[TBL] [Abstract][Full Text] [Related]
7. ZFPM2-AS1: An Oncogenic Long Non-coding RNA in Multiple Cancer Types.
Tan F
Mini Rev Med Chem; 2023; 23(1):88-98. PubMed ID: 35578882
[TBL] [Abstract][Full Text] [Related]
8. LncRNA ZFPM2-AS1 promotes lung adenocarcinoma progression by interacting with UPF1 to destabilize ZFPM2.
Han S; Cao D; Sha J; Zhu X; Chen D
Mol Oncol; 2020 May; 14(5):1074-1088. PubMed ID: 31919993
[TBL] [Abstract][Full Text] [Related]
9. ZFPM2-AS1 facilitates cell growth in esophageal squamous cell carcinoma via up-regulating TRAF4.
Sun G; Wu C
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32065218
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA TTN-AS1 promotes the metastasis in breast cancer by epigenetically activating DGCR8.
Qiu P; Dou Y; Ma LZ; Tang XX; Liu XL; Chen JW
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10835-10841. PubMed ID: 31858552
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of the long noncoding RNAs DSCAM-AS1 and MANCR is a potential diagnostic marker for breast carcinoma.
Tahmouresi F; Razmara E; Pakravan K; Mossahebi-Mohammadi M; Rouhollah F; Montazeri M; Sarrafzadeh A; Fahimi H; Babashah S
Biotechnol Appl Biochem; 2021 Dec; 68(6):1250-1256. PubMed ID: 33012018
[TBL] [Abstract][Full Text] [Related]
12. LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway.
Fang K; Hu C; Zhang X; Hou Y; Gao D; Guo Z; Li L
Carcinogenesis; 2020 Sep; 41(9):1273-1281. PubMed ID: 31784750
[TBL] [Abstract][Full Text] [Related]
13. LncRNA BRE-AS1 acts as a tumor suppressor factor in bladder cancer via mediating STAT3.
Zhang L; Liu B; Deng QH; Li JX
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5320-5328. PubMed ID: 32495865
[TBL] [Abstract][Full Text] [Related]
14. JMJD6 induces HOTAIR, an oncogenic lincRNA, by physically interacting with its proximal promoter.
Biswas A; Shettar A; Mukherjee G; Kondaiah P; Desai KV
Biochem J; 2018 Jan; 475(1):355-371. PubMed ID: 29229759
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA DLX6-AS1 promotes breast cancer progression via miR-505-3p/RUNX2 axis.
Zhao P; Guan H; Dai Z; Ma Y; Zhao Y; Liu D
Eur J Pharmacol; 2019 Dec; 865():172778. PubMed ID: 31705901
[TBL] [Abstract][Full Text] [Related]
16. HAND2-AS1 Works as a ceRNA of miR-3118 to Suppress Proliferation and Migration in Breast Cancer by Upregulating PHLPP2.
Dong G; Wang X; Jia Y; Jia Y; Zhao W; Zhang J; Tong Z
Biomed Res Int; 2020; 2020():8124570. PubMed ID: 33015182
[TBL] [Abstract][Full Text] [Related]
17. JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer.
Lee YF; Miller LD; Chan XB; Black MA; Pang B; Ong CW; Salto-Tellez M; Liu ET; Desai KV
Breast Cancer Res; 2012 May; 14(3):R85. PubMed ID: 22621393
[TBL] [Abstract][Full Text] [Related]
18. Role of lncRNA AGAP2-AS1 in Breast Cancer Cell Resistance to Apoptosis by the Regulation of MTA1 Promoter Activity.
Wu M; Wen L; Zhou Y; Wu W
Technol Cancer Res Treat; 2022; 21():15330338221085361. PubMed ID: 35369814
[No Abstract] [Full Text] [Related]
19. A high level of the long non-coding RNA
She Q; Chen Y; Liu H; Tan J; Li Y
Bioengineered; 2022 May; 13(5):13437-13451. PubMed ID: 36700469
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer.
Yang J; Wu W; Wu M; Ding J
In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):522-532. PubMed ID: 31264061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
